Wie hoch ist der Preis für Broncus Holding Corporation (2216)

Preis für Broncus Holding Corporation (2216) ist $0.08123316

Wie hoch ist die Marktkapitalisierung für Broncus Holding Corporation (2216)

Marktkapitalisierung für Broncus Holding Corporation (2216) ist $42.78M

Broncus Holding Corporation (2216) Kursverlauf

Broncus Holding Corporation is a global medical technology company specializing in the development of interventional pulmonology products. Its market reach extends across Mainland China, the European Union, the United States, and other international territories. The company's innovative product lineup includes advanced navigation systems such as LungPoint Virtual Bronchoscopic Navigation, a sophisticated computer-assisted image-based software solution. It also offers LungPoint Plus, a system providing real-time airway guidance crucial for lung biopsies and other medical interventions, and LungPro, a virtual bronchoscopic navigation product that enables three-dimensional real-time guided transbronchial needle aspiration alongside proprietary parenchymal navigation. Beyond navigation, Broncus provides a suite of therapeutic products. These feature InterVapor, a targeted bronchoscopic thermal vapor ablation system designed to treat diseased, hyper-inflated lung segments. Additionally, it offers an RF Generator paired with an RF Ablation Catheter, forming a radiofrequency ablation system specifically developed to target lung cancer. The H-Marker, a pulmonary surgical marker, is another key offering. The company further supplies a range of specialized procedural devices, including the BioStarNeedle, a single-use ultrasound-guided aspiration needle for retrieving tissue samples, and the FleXNeedle, a versatile multipurpose biopsy needle. Complementing these are various bronchoscopic accessories like the Archimedes Sheath, a sterile, single-use flexible tube that serves as a working channel during bronchoscopic procedures. The Archimedes Dilation Balloon, another sterile, single-use flexible tube with a distal balloon, is used to dilate target lung tissue within the bronchial tree after insertion through a bronchoscope or sheath. Finally, the Steerable Sheath provides a steerable adjustment handle and an additional working channel. Broncus Holding Corporation was established in 2012 and maintains its corporate headquarters in Hangzhou, China.

Jahr	Leistung
2026 (TTM)	-24.46%
2025	332.07%
2024	-25.34%
2023	-68.86%
2022	-73.15%
2021	0.00%

Jahr

Leistung

2026 (TTM)

-24.46%

2025

332.07%

2024

-25.34%

2023

-68.86%

2022

-73.15%

2021

0.00%

Unternehmen	Aktienkurs	Veränderung 1J%	Land
Abbott Laboratories ABT.US	$114.69	-13.40%	US
Stryker Corporation SYK.US	$331.94	-15.29%	US
Medtronic plc MDT.US	$92.76	-0.49%	IE
Boston Scientific Corporation BSX.US	$49.91	-52.94%	US
Siemens Healthineers AG SHL.DE	$47.22	-15.86%	DE

Unternehmen

Aktienkurs

Veränderung 1J%

Land